One of the rapidly advancing areas of medical research is neuro-ophthalmology. This subspecialty of ophthalmology deals with conditions of the eyes that are caused or impacted by the nervous system. Recent developments in the field have led to greater understanding and treatment of various disorders of the eye. A major development is the use of imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and electroencephalography (EEG). These techniques help to diagnose and evaluate diseases that affect the eye, as well as track the progression of certain eye conditions. The detailed imaging of these techniques can help ophthalmologists to detect and diagnose such eye disorders as choroidal neovascularization, glaucoma, macular degeneration, and other retinal diseases. Invasive surgical techniques are also being used to treat more serious types of neuro-ophthalmic disorders such as orbital tumors, optic nerve tumors, and strabismus. By using cutting-edge procedures such as transscleral sutures and laser techniques, ophthalmologists are able to more precisely treat these conditions and enhance outcomes. Innovative treatment options are also being explored, including stem cell treatments and gene therapy. Stem cells can be used to replace defective cells and can help retinal tissue regenerate. Gene therapy can be used to correct genetic defects in the eyes that are responsible for eye diseases. Both of these treatments can help to slow or even reverse the progress of a disease. In addition, new technology in the form of retinal implants and gene-editing are being researched and developed for use in neuro-ophthalmic study. These tools can help ophthalmologists identify different types of eye diseases earlier and more accurately. These recent advancements have already improved the treatment and diagnosis of eye conditions caused by the nervous system, and have the potential to revolutionize the field of neuro-ophthalmology. As research and technology in the field continue to progress, the hope is that even more effective treatments and therapies will be discovered.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States